Cover Image

Do all patients with atrial fibrillation need long-term anticoagulation?

Munish Sharma, Rohit Masih, Daniel A.N. Mascarenhas
  • Munish Sharma
    Department of Internal Medicine, Easton Hospital, Easton, PA, United States |
  • Rohit Masih
    Department of Internal Medicine, Easton Hospital, Easton, PA, United States
  • Daniel A.N. Mascarenhas
    Department of Cardiology, Easton Hospital, Easton, PA, United States


Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an estimated number of 2.7-6.1 million cases in the United States (US) alone. The incidence of AF is expected to increase 2.5 fold over the next 50 years in the US. The management of AF is complex and includes mainly three aspects; restoration of sinus rhythm, control of ventricular rate and prevention of systemic thromboembolism. AF as a cause of systemic embolization has been well known for many years, and majority of patients are on oral anticoagulants (OACs) to prevent this. Many times, a patient may not be in AF chronically, nor is the AF burden (the amount of time patient is in AF out of the total monitored time) calculated. We present three cases of new onset transient AF triggered by temporary stressors. We were able to restore normal sinus rhythm (NSR) with chemical cardioversion. As per 2014 American College of Cardiology (ACC)/American Heart Association (AHA) recommendations, we started all three patients on OACs based on CHA2DS2VASc score >2. However, the patients refused long term OACs after restoration of NSR and correction of the temporary enticing stressors. In any case, the decision to start OACs would have had its own risks. Here we describe how antiarrhythmic drugs were used to maintain NSR, all while they were continuously monitored to determine the need to continue OACs.


Atrial fibrillation; anticoagulation therapy.

Full Text:

Submitted: 2017-02-13 06:24:38
Published: 2017-07-31 12:34:26
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2017 Munish Sharma, Rohit Masih, Daniel A.N. Mascarenhas

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185